Log in

NASDAQ:AVCO - Avalon Globocare Stock Price, Forecast & News

-0.06 (-4.00 %)
(As of 12/8/2019 03:00 AM ET)
Today's Range
Now: $1.44
50-Day Range
MA: $1.54
52-Week Range
Now: $1.44
Volume37,819 shs
Average Volume287,096 shs
Market Capitalization$109.11 million
P/E RatioN/A
Dividend YieldN/A
Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. The company also develops proprietary diagnostic and therapeutic products leveraging exosome technology; and markets and distributes proprietary exosome isolation systems and related products, as well as provides development services for hospitals. In addition, it owns and operates real property. The company has a strategic partnership with Weill Cornell Medical College to co-develop technologies and bio-production of chimeric antigen receptor-T Therapy; a research and licensing agreement with Massachusetts Institute of Technology to develop technology for cellular therapy; and strategic partnership with GE Healthcare to enhance standardized automation and bio-production for cellular medicines. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.

Industry, Sector and Symbol

Industry Management consulting services
SectorBusiness Services
Current SymbolNASDAQ:AVCO



Sales & Book Value

Annual Sales$1.56 million
Book Value$0.15 per share


Net Income$-7,770,000.00
Net Margins-1,081.80%


Market Cap$109.11 million
Next Earnings Date3/24/2020 (Estimated)
OptionableNot Optionable

Receive AVCO News and Ratings via Email

Sign-up to receive the latest news and ratings for AVCO and its competitors with MarketBeat's FREE daily newsletter.

Avalon Globocare (NASDAQ:AVCO) Frequently Asked Questions

What is Avalon Globocare's stock symbol?

Avalon Globocare trades on the NASDAQ under the ticker symbol "AVCO."

How were Avalon Globocare's earnings last quarter?

Avalon Globocare Corp (NASDAQ:AVCO) issued its earnings results on Tuesday, November, 13th. The company reported ($0.03) earnings per share for the quarter. The firm had revenue of $0.41 million for the quarter. Avalon Globocare had a negative net margin of 1,081.80% and a negative return on equity of 164.86%. View Avalon Globocare's Earnings History.

When is Avalon Globocare's next earnings date?

Avalon Globocare is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for Avalon Globocare.

Has Avalon Globocare been receiving favorable news coverage?

Media coverage about AVCO stock has been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avalon Globocare earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an effect on the stock's share price in the immediate future. View News Stories for Avalon Globocare.

Are investors shorting Avalon Globocare?

Avalon Globocare saw a decrease in short interest in the month of November. As of November 15th, there was short interest totalling 677,300 shares, a decrease of 11.7% from the October 31st total of 766,900 shares. Based on an average daily volume of 78,600 shares, the short-interest ratio is presently 8.6 days. Approximately 3.1% of the company's shares are short sold. View Avalon Globocare's Current Options Chain.

Who are some of Avalon Globocare's key competitors?

What other stocks do shareholders of Avalon Globocare own?

Who are Avalon Globocare's key executives?

Avalon Globocare's management team includes the folowing people:
  • Dr. David K. Jin, CEO, Pres & Director (Age 51)
  • Ms. Luisa Ingargiola, Chief Financial Officer (Age 52)
  • Ms. Meng Li, COO, Sec. & Director (Age 41)
  • Dr. Yu Zhou M.D., Ph.D., Co-CEO & Director of GenExsome

Who are Avalon Globocare's major shareholders?

Avalon Globocare's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (0.36%), Sabby Management LLC (0.26%), Millennium Management LLC (0.05%), Squarepoint Ops LLC (0.03%) and Virtu Financial LLC (0.02%). Company insiders that own Avalon Globocare stock include Steven Philip Sukel and Wenzhao Lu. View Institutional Ownership Trends for Avalon Globocare.

Which institutional investors are selling Avalon Globocare stock?

AVCO stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC and Sabby Management LLC. View Insider Buying and Selling for Avalon Globocare.

Which institutional investors are buying Avalon Globocare stock?

AVCO stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, Squarepoint Ops LLC and Virtu Financial LLC. Company insiders that have bought Avalon Globocare stock in the last two years include Steven Philip Sukel and Wenzhao Lu. View Insider Buying and Selling for Avalon Globocare.

How do I buy shares of Avalon Globocare?

Shares of AVCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Avalon Globocare's stock price today?

One share of AVCO stock can currently be purchased for approximately $1.44.

How big of a company is Avalon Globocare?

Avalon Globocare has a market capitalization of $109.11 million and generates $1.56 million in revenue each year. Avalon Globocare employs 8 workers across the globe.View Additional Information About Avalon Globocare.

What is Avalon Globocare's official website?

The official website for Avalon Globocare is http://www.avalon-globocare.com/.

How can I contact Avalon Globocare?

Avalon Globocare's mailing address is 4400 Route 9 South Suite 3100, Freehold NJ, 07728. The company can be reached via phone at 732-780-4400 or via email at [email protected]

MarketBeat Community Rating for Avalon Globocare (NASDAQ AVCO)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  126 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  258
MarketBeat's community ratings are surveys of what our community members think about Avalon Globocare and other stocks. Vote "Outperform" if you believe AVCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVCO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Featured Article: Trading on Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel